title: Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome).
authors.forename: Edouard
authors.initials: E
authors.lastname: Gerbaud
authors.forename: Fabienne
authors.initials: F
authors.lastname: Tamion
authors.forename: Christophe
authors.initials: C
authors.lastname: Girault
authors.forename: Karine
authors.initials: K
authors.lastname: Clabault
authors.forename: Stephane
authors.initials: S
authors.lastname: Lepretre
authors.forename: Jacques
authors.initials: J
authors.lastname: Leroy
authors.forename: Guy
authors.initials: G
authors.lastname: Bonmarchand
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D007948:Leukemia, Monocytic, Acute / Q000150:complications; D008081:Liposomes; D008297:Male; D012964:Sodium / Q000652:urine; D014667:Vasopressins / Q000097:blood
chemical_list: D000935:Antifungal Agents; D008081:Liposomes; D014667:Vasopressins; D000666:Amphotericin B; D012964:Sodium